Of 16 G6PD-deficient or G6PD-intermediate patients who were administered tafenoquine, three (18·8%) completed day-5 follow-up, and one G6PD-deficient patient had signs of acute haemolytic anaemia but was already hospitalised as a precaution. Here, G6PD is linked to non-autoimmune hemolytic anemia.